abrdn plc Buys New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 484,666 shares of the biopharmaceutical company’s stock ...
SG Americas Securities LLC Has $220,000 Stake in argenx SE (NASDAQ:ARGX)
SG Americas Securities LLC increased its position in argenx SE (NASDAQ:ARGX – Free Report) by 6.2% in the 4th quarter, ...
Baird starts Catalyst Pharma with Outperform, $28 target
Baird initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ:CPRX) with an Outperform rating and set a price target ...
Catalyst Pharmaceuticals initiated with an Outperform at Baird
Baird analyst Joel Beatty last night initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target ...
American Association of Individual Investors2 天
Which Is a Better Investment, Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc ...
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
Fintel on MSN3 天
Baird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform Recommendation
Fintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a ...
stocknews5 天
3 Niche Healthcare Stocks Tackling Rare Diseases
The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...
Palantir upgraded, Nio downgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...